Biologic Imaging Reagents Market To Double
|
By MedImaging International staff writers Posted on 22 Jan 2009 |
|
According to a new technical market research report, the global market for biologic imaging reagent technology is expected to be worth US$5.8 billion in 2008. This will increase to over $9.5 billion in 2013, for a compound annual growth rate (CAGR) of 10.2%.
The market report, from BCC Research (Wellesley, MA, USA), is broken down into contrast reagents, optical reagents, and nuclear reagents. Of these, contrast reagents have the largest share of the market, worth an estimated $2.6 billion in 2008. This should increase to $3.7 billion in 2013, for a CAGR of 7.2%.
Nuclear reagents have the second largest market share, generating an estimated $2.1 billion in 2008. This is expected to increase at a CAGR of 12.5% to reach $3.7 billion in 2013. The third largest share of the market belongs to optical reagents, with sales of over $1.2 billion in 2008. This should reach $2.1 billion in 2013, for a CAGR of 12.1%.
Biologic imaging reagents play a fundamental role in current medical, pharmaceutical, and biotechnology industries. Optical imaging reagents allow life sciences researchers and drug developers to visualize and detect biologic processes at the molecular level and to perform key genomics, proteomics and cellular analysis assays. Nuclear and contrast reagents provide important diagnostic information to physicians, enabling the early detection and treatment of disease conditions in cardiology, neurology and oncology.
Technology and market forces are creating a key shift in biologic imaging reagents toward highly specific, multifunctional reagents, according to BBC Research analysts. This shift is creating opportunities for reagent manufacturers to address strategic market opportunities in genomics, proteomics, live cell imaging, early detection of cancers and neurological disorders, drug development, and hybrid imaging/therapeutic reagents.
A main competitive strategy for achieving success in biologic imaging reagents businesses has been acquiring unique technology in fluorescent proteins, fluorescence dyes and probes, quantum dots, and nanotechnology. A second route to gaining technologic competitive advantage is through strategic industry alliances.
BCC Research is a publisher of market research reports and technical publications.
Related Links:
BCC Research
The market report, from BCC Research (Wellesley, MA, USA), is broken down into contrast reagents, optical reagents, and nuclear reagents. Of these, contrast reagents have the largest share of the market, worth an estimated $2.6 billion in 2008. This should increase to $3.7 billion in 2013, for a CAGR of 7.2%.
Nuclear reagents have the second largest market share, generating an estimated $2.1 billion in 2008. This is expected to increase at a CAGR of 12.5% to reach $3.7 billion in 2013. The third largest share of the market belongs to optical reagents, with sales of over $1.2 billion in 2008. This should reach $2.1 billion in 2013, for a CAGR of 12.1%.
Biologic imaging reagents play a fundamental role in current medical, pharmaceutical, and biotechnology industries. Optical imaging reagents allow life sciences researchers and drug developers to visualize and detect biologic processes at the molecular level and to perform key genomics, proteomics and cellular analysis assays. Nuclear and contrast reagents provide important diagnostic information to physicians, enabling the early detection and treatment of disease conditions in cardiology, neurology and oncology.
Technology and market forces are creating a key shift in biologic imaging reagents toward highly specific, multifunctional reagents, according to BBC Research analysts. This shift is creating opportunities for reagent manufacturers to address strategic market opportunities in genomics, proteomics, live cell imaging, early detection of cancers and neurological disorders, drug development, and hybrid imaging/therapeutic reagents.
A main competitive strategy for achieving success in biologic imaging reagents businesses has been acquiring unique technology in fluorescent proteins, fluorescence dyes and probes, quantum dots, and nanotechnology. A second route to gaining technologic competitive advantage is through strategic industry alliances.
BCC Research is a publisher of market research reports and technical publications.
Related Links:
BCC Research
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Digital Color Doppler Ultrasound System
MS22Plus
High-Precision QA Tool
DEXA Phantom
Post-Processing Imaging System
DynaCAD Prostate
Latest General/Advanced Imaging News
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
- AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
- CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
Channels
Radiography
view channel
X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
Detecting early-stage cancer or subtle changes deep inside tissues has long challenged conventional X-ray systems, which rely only on how structures absorb radiation. This limitation keeps many microstructural... Read more
AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
Osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide, is the leading cause of disability among older adults. Current diagnostic tools allow doctors to assess damage... Read more
MRI
view channel
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
Ultrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read more
Nuclear Medicine
view channel
PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more
Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
Aggressive cancers such as osteosarcoma and glioblastoma often resist standard therapies, thrive in hostile tumor environments, and recur despite surgery, radiation, or chemotherapy. These tumors also... Read more
New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more